These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33946813)

  • 1. Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid.
    Hernandez-Valladares M; Wangen R; Aasebø E; Reikvam H; Berven FS; Selheim F; Bruserud Ø
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells.
    Reikvam H; Hovland R; Forthun RB; Erdal S; Gjertsen BT; Fredly H; Bruserud Ø
    BMC Cancer; 2017 Sep; 17(1):630. PubMed ID: 28877686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy.
    Grønningsæter IS; Fredly HK; Gjertsen BT; Hatfield KJ; Bruserud Ø
    Cells; 2019 Oct; 8(10):. PubMed ID: 31658693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
    Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
    Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.
    Bug G; Ritter M; Wassmann B; Schoch C; Heinzel T; Schwarz K; Romanski A; Kramer OH; Kampfmann M; Hoelzer D; Neubauer A; Ruthardt M; Ottmann OG
    Cancer; 2005 Dec; 104(12):2717-25. PubMed ID: 16294345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional corepressor CBFA2T3 inhibits all-
    Steinauer N; Guo C; Zhang J
    J Biol Chem; 2020 Jul; 295(27):8887-8900. PubMed ID: 32434928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
    Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo biological effects of ATRA in the treatment of AML.
    Ryningen A; Stapnes C; Paulsen K; Lassalle P; Gjertsen BT; Bruserud O
    Expert Opin Investig Drugs; 2008 Nov; 17(11):1623-33. PubMed ID: 18922099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
    Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
    J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment.
    Fredly H; Reikvam H; Gjertsen BT; Bruserud O
    Am J Hematol; 2012 Apr; 87(4):368-76. PubMed ID: 22374841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
    Rashid A; Wang R; Zhang L; Yue J; Yang M; Yen A
    Exp Cell Res; 2020 Sep; 394(1):111989. PubMed ID: 32283065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
    Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
    Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid.
    Ersvaer E; Brenner AK; Vetås K; Reikvam H; Bruserud Ø
    BMC Pharmacol Toxicol; 2015 May; 16():12. PubMed ID: 25934555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.
    Steinmetz B; Hackl H; Slabáková E; Schwarzinger I; Smějová M; Spittler A; Arbesu I; Shehata M; Souček K; Wieser R
    Cell Cycle; 2014; 13(18):2931-43. PubMed ID: 25486480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells.
    Shao X; Xiang S; Fu H; Chen Y; Xu A; Liu Y; Qi X; Cao J; Zhu H; Yang B; He Q; Ying M
    Pharmacol Res; 2020 Jan; 151():104545. PubMed ID: 31740384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bromodomain Inhibitor JQ1 Enhances the Responses to All-
    Kang C; Kim CY; Kim HS; Park SP; Chung HM
    Int J Stem Cells; 2018 May; 11(1):131-140. PubMed ID: 29699387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation.
    Bruserud Ø; Tsykunova G; Hernandez-Valladares M; Reikvam H; Tvedt THA
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34063204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia.
    Fredly H; Ersvær E; Kittang AO; Tsykunova G; Gjertsen BT; Bruserud O
    Clin Epigenetics; 2013 Aug; 5(1):13. PubMed ID: 23915396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia--a report of five cases.
    Fredly H; Stapnes Bjørnsen C; Gjertsen BT; Bruserud Ø
    Hematology; 2010 Oct; 15(5):338-43. PubMed ID: 20863429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.